MAXIMUS, Inc. (MMS) Shares Sold by Stephens Inc. AR
Stephens Inc. AR decreased its holdings in shares of MAXIMUS, Inc. (NYSE:MMS) by 13.2% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 5,694 shares of the health services provider’s stock after selling 869 shares during the period. Stephens Inc. AR’s holdings in MAXIMUS were worth $408,000 at the end of the most recent reporting period.
Other large investors have also bought and sold shares of the company. Public Employees Retirement System of Ohio boosted its stake in MAXIMUS by 42.1% during the third quarter. Public Employees Retirement System of Ohio now owns 104,056 shares of the health services provider’s stock valued at $6,712,000 after buying an additional 30,804 shares during the period. OxFORD Asset Management LLP boosted its stake in MAXIMUS by 338.0% during the third quarter. OxFORD Asset Management LLP now owns 33,885 shares of the health services provider’s stock valued at $2,186,000 after buying an additional 26,148 shares during the period. Cornerstone Capital Management Holdings LLC. boosted its stake in MAXIMUS by 798.2% during the third quarter. Cornerstone Capital Management Holdings LLC. now owns 172,286 shares of the health services provider’s stock valued at $11,110,000 after buying an additional 153,104 shares during the period. Jane Street Group LLC bought a new stake in MAXIMUS during the third quarter valued at $359,000. Finally, Wells Fargo & Company MN boosted its stake in MAXIMUS by 8.8% during the third quarter. Wells Fargo & Company MN now owns 112,612 shares of the health services provider’s stock valued at $7,264,000 after buying an additional 9,147 shares during the period. 95.55% of the stock is owned by institutional investors.
Several equities research analysts recently issued reports on MMS shares. Canaccord Genuity dropped their price objective on MAXIMUS from $62.00 to $61.00 and set a “hold” rating for the company in a research note on Friday, November 10th. Zacks Investment Research downgraded MAXIMUS from a “hold” rating to a “sell” rating in a research report on Tuesday, November 14th. Finally, Maxim Group restated a “hold” rating and set a $69.00 price target (up previously from $66.00) on shares of MAXIMUS in a research report on Thursday, February 8th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $66.60.
MAXIMUS (NYSE:MMS) last released its quarterly earnings results on Thursday, February 8th. The health services provider reported $0.78 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.77 by $0.01. MAXIMUS had a return on equity of 22.93% and a net margin of 8.99%. The business had revenue of $623.10 million for the quarter, compared to the consensus estimate of $624.36 million. During the same quarter last year, the business posted $0.71 earnings per share. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. equities research analysts forecast that MAXIMUS, Inc. will post 3.44 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th will be given a dividend of $0.045 per share. The ex-dividend date is Wednesday, February 14th. This represents a $0.18 dividend on an annualized basis and a yield of 0.28%. MAXIMUS’s payout ratio is 5.36%.
In other news, Director Russell A. Beliveau sold 1,000 shares of MAXIMUS stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $71.73, for a total value of $71,730.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Mark Andrekovich sold 5,594 shares of MAXIMUS stock in a transaction dated Wednesday, November 22nd. The stock was sold at an average price of $67.23, for a total value of $376,084.62. Following the completion of the transaction, the insider now owns 27,996 shares in the company, valued at approximately $1,882,171.08. The disclosure for this sale can be found here. Insiders have sold 69,617 shares of company stock worth $4,789,052 in the last 90 days. Company insiders own 2.48% of the company’s stock.
WARNING: “MAXIMUS, Inc. (MMS) Shares Sold by Stephens Inc. AR” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.watchlistnews.com/maximus-inc-mms-shares-sold-by-stephens-inc-ar/1865446.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.